Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Vivimed Labs Limited
VIVIMEDLABVivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments, Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India. Address: NCC House, (Western Wing), Hyderabad, India, 500 081
Analytics
Precio Objetivo de WallStreet
11 305.98 INRRelación P/E
–Rentabilidad por dividendo
–Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave VIVIMEDLAB
Análisis de dividendos VIVIMEDLAB
Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout VIVIMEDLAB
Valoración de la acción VIVIMEDLAB
Finanzas VIVIMEDLAB
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |